| 0.0011 0 (0%) | 06-08 09:30 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 1-year : | ||
| Resists | First : | Second : | ||
| Pivot price | ||||
| Supports | First : | Second : | ||
| MAs | MA(5) : | MA(20) : | ||
| MA(100) : | MA(250) : | |||
| MACD | MACD : | Signal : | ||
| %K %D | K(14,3) : | D(3) : | ||
| RSI | RSI(14): | |||
| 52-week | High : | Low : | ||
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
iCoreConnect Inc. operates as a U.S.-based technology enterprise, specializing in cloud-hosted software-as-a-service (SaaS) solutions engineered to adhere to Health Insurance Portability and Accountability Act (HIPAA) standards. The company offers a diverse portfolio of products, including: iCoreRx: An electronic prescribing application that maintains HIPAA compliance. iCorePDMP: A system for checking a patient's Prescription Drug Monitoring Program history before controlled substances are prescribed. iCoreVerify and iCoreVerify+: HIPAA-compliant SaaS solutions that automate the retrieval of a patient's insurance eligibility details, verifying benefits both proactively before appointments and on demand. iCoreHuddle and iCoreHuddle+: Tools designed to quickly assess the potential revenue generated by each patient. iCoreCodeGenius: A SaaS-based reference tool for medical coding. Beyond these, iCoreConnect Inc. provides: iCoreExchange: A secure email SaaS, allowing healthcare professionals to confidentially send and receive messages with attachments. iCoreCloud: Services for backing up on-premise servers and computers to the cloud. iCoreClaims: A system for processing and managing claims submitted by policyholders or dental providers. iCorePay: A platform for processing patient payments and overseeing revenue cycles. iCoreSecure: A robust SaaS solution addressing privacy concerns across various sectors, such as insurance, real estate, and finance. iCoreIT: Offerings in managed information technology services. Founded in 1992, the company was initially known as iMedicor, Inc., changing its name to iCoreConnect Inc. in June 2017. Its corporate headquarters are located in Ocoee, Florida.
Tue, 10 Jun 2025
Ocoee-based tech company files for bankruptcy amid Nasdaq delisting threat - The Business Journals
Tue, 03 Jun 2025
icoreconnect inc. files for chapter 11 bankruptcy protection - Investing.com
Thu, 22 May 2025
iCoreConnect to be delisted from Nasdaq - Investing.com
Wed, 14 May 2025
iCoreConnect Stock Soars: Should You Buy? - StocksToTrade
Mon, 21 Apr 2025
iCoreConnect faces Nasdaq delisting over late filing - Investing.com
Thu, 27 Feb 2025
Growth or Buble? The Rapid Rise of ICCT - StocksToTrade
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
OTC
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | (%) |
| Held by Institutions | (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | |
| EPS Est Next Qtrly | |
| EPS Est This Year | |
| EPS Est Next Year | |
| Book Value (p.s.) | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets (ttm) | % |
| Return on Equity (ttm) | % |
| Qtrly Rev. Growth | % |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | |
| Price to Cash Flow |
| Dividend | |
| Forward Dividend | |
| Dividend Yield | 0% |
| Dividend Pay Date | |
| Ex-Dividend Date |
|
|
|
|
|
|
|
|
|